Prevention of hemolytic uremic syndrome with daily bowel lavage in patients with Shiga toxin-producing enterohemorrhagic Escherichia coli O104:H4 infection.
Department of Medicine I, University Hospital Hamburg-Eppendorf, Hamburg, Germany.
Stefan
S
Lüth
Department of Medicine I, University Hospital Hamburg-Eppendorf, Hamburg, Germany.
Thorben W
TW
Fründt
Department of Interdisciplinary Endoscopy, University Hospital Hamburg-Eppendorf, Hamburg, Germany.
Thomas
T
Rösch
Department of Medicine I, University Hospital Hamburg-Eppendorf, Hamburg, Germany.
Christoph
C
Schlee
Department of Medicine I, University Hospital Hamburg-Eppendorf, Hamburg, Germany.
Ansgar W
AW
Lohse
D000293:Adolescent; D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D054324:Enterohemorrhagic Escherichia coli; D004927:Escherichia coli Infections / Q000150:complications* / Q000382:microbiology / Q000628:therapy; D005260:Female; D006463:Hemolytic-Uremic Syndrome / Q000382:microbiology / Q000517:prevention & control*; D006801:Humans; D008297:Male; D008875:Middle Aged; D011092:Polyethylene Glycols / Q000008:administration & dosage*; D012189:Retrospective Studies; D013501:Surface-Active Agents / Q000008:administration & dosage*; D007507:Therapeutic Irrigation; D055815:Young Adult
D013501:Surface-Active Agents; D011092:Polyethylene Glycols